• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatr Infect Dis J . Recurrent SARS-CoV-2 Infection and Impaired Immunologic Response in a Pediatric Oncologic Patient While Treated With Radioch

tetano

Editor, Senior Moderator
Pediatr Infect Dis J


. 2022 Apr 21.
doi: 10.1097/INF.0000000000003515. Online ahead of print.
Recurrent SARS-CoV-2 Infection and Impaired Immunologic Response in a Pediatric Oncologic Patient While Treated With Radiochemotherapy


Thomas Eichholz[SUP] 1 [/SUP], Anne-Marie Arendt[SUP] 1 [/SUP], Ursula Holzer[SUP] 1 [/SUP], Christian Seitz[SUP] 1 [/SUP], Armin Rabsteyn[SUP] 1 [/SUP], Tina Ganzenmueller[SUP] 2 [/SUP], Reinhild Klein[SUP] 3 [/SUP], Juliane Walz[SUP] 4 5 6 7 [/SUP], Peter Lang[SUP] 1 [/SUP]



Affiliations

Abstract

Immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pediatric patients with malignant disease may be affected by tumor therapy. Here, we report the case of a child with rhabdomyosarcoma and recurrent SARS-CoV-2 infection. Immunologic responses, analyzed by T-cell activity and anti-viral IgG levels, were impaired and not durable as a result of intensive radiochemotherapy.
 
Back
Top Bottom